If you are having trouble reading this email, read the online version

WHITE PAPER

Clinical trial of EpiCor impacts cold and flu symptoms on healthy adults

When given EpiCor, a postbiotic fermentate made from yeast, to healthy adults both with and without a flu vaccination in a clinical trial, subjects experienced a statistically significant decrease in cold and flu symptoms.

Download this white paper from Embria Health to see the results of the study.

Download the white paper to learn more

This email was sent to you by the Informa Markets Division of Informa PLC (Privacy Policy).
Informa PLC's registered office is 5 Howick Place, London SW1P 1WG.
Registered in England and Wales. Number 8860726.

If you do not wish to receive further information from us, please click here.
Alternatively, to contact our data services team to have your details or preferences updated please email imdatateam@informa.com.